'I Say, I Say, Don't Be a Chicken!' About Colon Cancer Screening: Taxi-Top Ads and PSA Videos

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 4
Volume 16
Issue 4

The Jay Monahan Center for Gastrointestinal Health at New York-Presbyterian Hospital/Weill Cornell Medical Center is teaming up with New York City's taxi drivers to remind New Yorkers and visitors to the city to get screened for colon cancer.

NEW YORK—The Jay Monahan Center for Gastrointestinal Health at New York-Presbyterian Hospital/Weill Cornell Medical Center is teaming up with New York City's taxi drivers to remind New Yorkers and visitors to the city to get screened for colon cancer. This unique and fun public outreach campaign will be featured in and on taxis throughout New York City, and is being conducted in collaboration with the NYC Taxi and Limousine Commission, the Metropolitan Taxicab Board of Trade, the NYC Department of Health and Mental Hygiene, and the city's 311 information line.

The campaign features taxi-top advertisements of the Warner Brothers cartoon character Foghorn Leghorn and in-taxi video PSAs with actor Jimmy Smits, both promoting colon cancer screening.

Foghorn Leghorn, voiced by Mel Blanc, was created in 1946 and thus should be well known to the generation old enough to be candidates for colon cancer screening. Foghorn may seem an odd choice, but this Southern gentleman rooster's blustering voice, which rings in the ears of the Baby Boomers, may be just the impetus needed for some people age 50 and over to schedule this important screening test.

[Editor's Note: This publication's 50-something executive editor recently had her first colonoscopy screening exam, in the interest of cancer prevention and to "set a good example." By the time I reached the outpatient surgical facility, I was feeling lightheaded from hunger and apologized to the nurse for not being entirely coherent as she asked questions and inserted an IV line into my dehydrated veins. "Almost no one drinks enough water," she commented. "I want a hamburger," I replied. I'll see her again in 10 years.]

Recent Videos
Prolonging systemic therapy in patients with gastric or gastroesophageal junction cancers may offer better outcomes than radiation therapy.
Advances in perioperative targeted therapies may enable organ preservation and significantly enhance outcomes for patients with gastric cancers.
Combining sotorasib with panitumumab may reduce the burden of disease in patients with KRAS G12C-mutated metastatic colorectal cancer.
Findings from the CodeBreak 300 study have cemented sotorasib/panitumumab as a third-line treatment option for KRAS G12C-mutated colorectal cancer.
Sotorasib plus panitumumab may offer improved survival compared with previously approved treatment options in KRAS G12C-mutated colorectal cancer.
Additional local, regional, or national policy may bolster access to screening for colorectal cancer, according to Aasma Shaukat, MD, MPH.
The mechanism of action for daraxonrasib inhibits effectors and signaling while forming a relatively unstable tri-complex with codon 12 mutations.
Related Content